These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 2952417

  • 1. The identification of aldose reductase in the pathogenesis of diabetic complications: the background.
    Kador PF, Kinoshita JH.
    Diabet Med; 1985 May; 2(3):187-9. PubMed ID: 2952417
    [No Abstract] [Full Text] [Related]

  • 2. Aldose reductase in diabetic cataracts.
    Kinoshita JH, Kador P, Catiles M.
    JAMA; 1981 Jul 17; 246(3):257-61. PubMed ID: 6787220
    [No Abstract] [Full Text] [Related]

  • 3. Immunohistochemical localization for aldose reductase in diabetic lenses.
    Akagi Y, Kador PF, Kinoshita JH.
    Invest Ophthalmol Vis Sci; 1987 Jan 17; 28(1):163-7. PubMed ID: 3100473
    [Abstract] [Full Text] [Related]

  • 4. Lens metabolism and cellular effects of aldose reductase.
    McLean P, Gonzalez AM, Sochor M, Hothersall JS.
    Diabet Med; 1985 May 17; 2(3):189-93. PubMed ID: 2952418
    [No Abstract] [Full Text] [Related]

  • 5. Inhibition of polyol pathway activity in diabetic and galactosemic rats by the aldose reductase inhibitor CP-45,634.
    Peterson MJ, Sarges R, Aldinger CE, MacDonald DP.
    Adv Exp Med Biol; 1979 May 17; 119():347-56. PubMed ID: 115231
    [No Abstract] [Full Text] [Related]

  • 6. Aldose reductase and the etiology of diabetic cataracts.
    Varma SD.
    Curr Top Eye Res; 1980 May 17; 3():91-155. PubMed ID: 6807610
    [No Abstract] [Full Text] [Related]

  • 7. Conference report. The polyol pathway and complications of diabetes.
    Ward JD.
    Br J Clin Pract; 1986 Mar 17; 40(3):118-22. PubMed ID: 3085699
    [No Abstract] [Full Text] [Related]

  • 8. Activation of aldose reductase by nonenzymatic glycosylation.
    Srivastava SK, Ansari NH, Bhatnagar A, Hair G, Liu S, Das B.
    Prog Clin Biol Res; 1989 Mar 17; 304():171-84. PubMed ID: 2506561
    [Abstract] [Full Text] [Related]

  • 9. The aldose reductase controversy.
    Frank RN.
    Diabetes; 1994 Feb 17; 43(2):169-72. PubMed ID: 8288039
    [No Abstract] [Full Text] [Related]

  • 10. Diabetic cataracts in animal models: prevention and reversibility with aldose reductase inhibitors.
    Kador PF, Akagi Y, Kinoshita JH.
    Diabet Med; 1985 May 17; 2(3):194-6. PubMed ID: 2952419
    [No Abstract] [Full Text] [Related]

  • 11. Aldose reductase in the etiology of diabetic complications: I. Introduction.
    Harrison HE, Stribling D, Armstrong FM, Perkins CM.
    J Diabet Complications; 1989 May 17; 3(1):6-11. PubMed ID: 2540215
    [No Abstract] [Full Text] [Related]

  • 12. Role of aldose reductase in the development of diabetes-associated complications.
    Kador PF, Kinoshita JH.
    Am J Med; 1985 Nov 15; 79(5A):8-12. PubMed ID: 3934965
    [Abstract] [Full Text] [Related]

  • 13. Aldose reductase inhibitors and diabetic complications.
    Raskin P, Rosenstock J.
    Am J Med; 1987 Aug 15; 83(2):298-306. PubMed ID: 3113248
    [No Abstract] [Full Text] [Related]

  • 14. [Effect of insulin on aldose reductase activity in the lens of rats with streptozotocin-induced diabetes].
    Nishigami T.
    Nippon Ganka Gakkai Zasshi; 1990 Feb 15; 94(2):128-34. PubMed ID: 2114733
    [Abstract] [Full Text] [Related]

  • 15. The effect of high glucose and oxidative stress on lens metabolism, aldose reductase, and senile cataractogenesis.
    Cheng HM, González RG.
    Metabolism; 1986 Apr 15; 35(4 Suppl 1):10-4. PubMed ID: 3083198
    [Abstract] [Full Text] [Related]

  • 16. Relative importance of aldose reductase versus nonenzymatic glycosylation on sugar cataract formation in diabetic rats.
    Kador PF, Lee JW, Fujisawa S, Blessing K, Lou MF.
    J Ocul Pharmacol Ther; 2000 Apr 15; 16(2):149-60. PubMed ID: 10803425
    [Abstract] [Full Text] [Related]

  • 17. Aldose reductase in the diabetic eye. XLIII Edward Jackson memorial lecture.
    Kinoshita JH.
    Am J Ophthalmol; 1986 Dec 15; 102(6):685-92. PubMed ID: 3098107
    [Abstract] [Full Text] [Related]

  • 18. Lens aldose reductase in diabetic and galactosemic cataracts.
    Parmar NS, Ghosh MN.
    Indian J Physiol Pharmacol; 1981 Dec 15; 25(3):193-200. PubMed ID: 6795119
    [No Abstract] [Full Text] [Related]

  • 19. The effect of aldose reductase and its inhibition on sugar cataract formation.
    Kador PF, Akagi Y, Kinoshita JH.
    Metabolism; 1986 Apr 15; 35(4 Suppl 1):15-9. PubMed ID: 3083204
    [Abstract] [Full Text] [Related]

  • 20. Studies on cataractogenesis in humans and in rats with alloxan-induced diabetes. II. Histochemical evaluation of lenticular enzymes.
    Ahmad SS, Tsou KC, Ahmad SI, Rahman MA.
    Ophthalmic Res; 1985 Apr 15; 17(1):12-20. PubMed ID: 2984623
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.